These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


345 related items for PubMed ID: 3014000

  • 1. Human retroviral env and gag polypeptides: serologic assays to measure infection.
    Kanner SB, Cheng-Mayer C, Geffin RB, Parks WP, Beltz GA, Arthur LO, Samuel KP, Papas TS.
    J Immunol; 1986 Jul 15; 137(2):674-8. PubMed ID: 3014000
    [Abstract] [Full Text] [Related]

  • 2. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [Abstract] [Full Text] [Related]

  • 3. HTLV and immunosuppression.
    Essex M, Kanki P, Allan J, Barin F, McLane MF, Lee TH, Kitchen L, Homma T, Malone G, Yokota T.
    Princess Takamatsu Symp; 1984 Sep 15; 15():309-18. PubMed ID: 6100649
    [Abstract] [Full Text] [Related]

  • 4. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
    Fischinger PJ, Robey WG, Koprowski H, Gallo RC, Bolognesi DP.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
    [Abstract] [Full Text] [Related]

  • 5. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS.
    J Immunol; 1987 Feb 15; 138(4):1064-7. PubMed ID: 3027168
    [Abstract] [Full Text] [Related]

  • 6. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).
    Kanki PJ, Barin F, M'Boup S, Allan JS, Romet-Lemonne JL, Marlink R, McLane MF, Lee TH, Arbeille B, Denis F.
    Science; 1986 Apr 11; 232(4747):238-43. PubMed ID: 3006256
    [Abstract] [Full Text] [Related]

  • 7. Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
    Ohta M, Ohta K, Mori F, Nishitani H, Saida T.
    J Immunol; 1986 Dec 01; 137(11):3440-3. PubMed ID: 3023483
    [Abstract] [Full Text] [Related]

  • 8. Structural and epidemiological features of primate lymphotropic retroviruses.
    Hunsmann G, Schneider J, Bayer H, Jurkiewicz E, Yamamoto N.
    Princess Takamatsu Symp; 1984 Dec 01; 15():109-18. PubMed ID: 6100632
    [Abstract] [Full Text] [Related]

  • 9. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.
    Sarngadharan MG, diMarzo Veronese F, Lee S, Gallo RC.
    Cancer Res; 1985 Sep 01; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106
    [Abstract] [Full Text] [Related]

  • 10. Production of oncogene-specific proteins and human T-cell leukemia (lymphotropic) retrovirus (HTLV-I) envelope protein in bacteria and its potential for use in human cancers and seroepidemiological surveys.
    Papas TS, Samuel KP, Kan NC, Ascione R, Wong-Staal F, Lautenberger JA.
    Cancer Res; 1985 Sep 01; 45(9 Suppl):4568s-4573s. PubMed ID: 2861893
    [Abstract] [Full Text] [Related]

  • 11. [Molecular biology of human T-lymphotropic retroviruses (HTLV)].
    Dorner F, Barrett PN, Schmidt BL, Bodemer W.
    Wien Med Wochenschr; 1986 Apr 30; 136(7-8):181-8. PubMed ID: 2425498
    [Abstract] [Full Text] [Related]

  • 12. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR, Strick N, Sproul P, Baker L, Rubinstein P, Stevens CE, Taylor P, Gallo RC, Gold JW, Lee YS.
    J Virol Methods; 1985 May 30; 11(1):75-86. PubMed ID: 2989312
    [Abstract] [Full Text] [Related]

  • 13. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA.
    Nature; 1985 May 30; 322(6078):470-4. PubMed ID: 3016552
    [Abstract] [Full Text] [Related]

  • 14. Structural and antigenic characterization of the proteins of human T-cell leukemia viruses and their relationships to the gene products of other retroviruses.
    Oroszlan S, Copeland TD, Rice NR, Smythers GW, Tsai WP, Yoshinaka Y, Shimotohno K.
    Princess Takamatsu Symp; 1984 May 30; 15():147-57. PubMed ID: 6100635
    [Abstract] [Full Text] [Related]

  • 15. Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Essex M, Allan J, Kanki P, McLane MF, Malone G, Kitchen L, Lee TH.
    Ann Intern Med; 1985 Nov 30; 103(5):700-3. PubMed ID: 2996402
    [Abstract] [Full Text] [Related]

  • 16. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
    Nicholson JK, Cross GD, Callaway CS, McDougal JS.
    J Immunol; 1986 Jul 01; 137(1):323-9. PubMed ID: 3011909
    [Abstract] [Full Text] [Related]

  • 17. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.
    Barin F, McLane MF, Allan JS, Lee TH, Groopman JE, Essex M.
    Science; 1985 May 31; 228(4703):1094-6. PubMed ID: 2986291
    [Abstract] [Full Text] [Related]

  • 18. Delineation of type-specific regions on the envelope glycoproteins of human T cell leukemia viruses.
    Chen YM, Zhang XQ, Dahl CE, Samuel KP, Schooley RT, Essex M, Papas TS.
    J Immunol; 1991 Oct 01; 147(7):2368-76. PubMed ID: 1717557
    [Abstract] [Full Text] [Related]

  • 19. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
    Lipka K, Tebbe B, Finckh U, Rolfs A.
    Clin Exp Dermatol; 1996 Jan 01; 21(1):38-42. PubMed ID: 8689767
    [Abstract] [Full Text] [Related]

  • 20. Expression of AIDS virus envelope gene in recombinant vaccinia viruses.
    Hu SL, Kosowski SG, Dalrymple JM.
    Nature; 1996 Jan 01; 320(6062):537-40. PubMed ID: 3008002
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.